monovalent oral poliovirus vaccine type 1
Showing 1 - 25 of >10,000
Poliomyelitis Trial in Dhaka (mOPV1, bOPV, fIPV)
Completed
- Poliomyelitis
- mOPV1
- +2 more
-
Dhaka, Bangladeshicddr,b study clinics (Mirpur and CTU Dhaka)
Feb 18, 2021
Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),
Not yet recruiting
- Poliomyelitis
- Novel oral poliomyelitis vaccine type 1 (nOPV1)
- +3 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research
Nov 14, 2023
Polio Trial (polio vaccines: nOPV2, bOPV, IPV)
Not yet recruiting
- Polio
- polio vaccines: nOPV2, bOPV, IPV
- (no location specified)
Nov 2, 2023
Poliomyelitis Trial in Dhaka (Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1), Sabin Monovalent Oral
Not yet recruiting
- Poliomyelitis
- Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1)
- Sabin Monovalent Oral Poliomyelitis Vaccine Type 1 (mOPV1)
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh
Nov 30, 2022
Poliomyelitis Trial in United States (Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin
Active, not recruiting
- Poliomyelitis
- Novel Oral Polio Vaccine Type 1 (nOPV1)
- +3 more
-
Baltimore, Maryland
- +3 more
Aug 24, 2022
Poliomyelitis Trial in Panama City (Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3), Sabin Monovalent Oral
Not yet recruiting
- Poliomyelitis
- Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
- Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
-
Panama City, Panama
- +3 more
Dec 14, 2022
Polio Trial in Antwerpen (IMOVAX Inactivated Poliomyelitis Vaccine (IPV), dmLT (adjuvant), Bivalent oral polio vaccine (bOPV))
Completed
- Polio
- Inactivated Poliomyelitis Vaccine (IPV)
- +2 more
-
Antwerpen, Wilrijk, BelgiumUniversity of Antwerpen
Apr 5, 2022
Poliomyelitis Trial in Wilrijk, Ghent (Novel OPV2 candidate 1, Novel OPV2 candidate 2, Placebo)
Completed
- Poliomyelitis
- Novel OPV2 candidate 1
- +2 more
-
Wilrijk, Antwerp, Belgium
- +1 more
Sep 18, 2021
Poliomyelitis Trial in David, Panamá (nOPV2 (monovalent oral polio vaccine))
Completed
- Poliomyelitis
- nOPV2 (monovalent oral polio vaccine)
-
David, Chiriquí, Panama
- +1 more
Jan 20, 2022
Norovirus Infections Trial in Cypress (VXA-G1.1-NN)
Completed
- Norovirus Infections
- VXA-G1.1-NN
-
Cypress, CaliforniaWCCT Global, Inc.
Sep 19, 2022
GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))
Completed
- GBM
- +3 more
- Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
-
Durham, North CarolinaDuke University Medical Center
Jun 28, 2022
Norovirus Infection Trial in Cleveland (VXA-G1.1-NN, VXA-G2.4-NS, Placebo Tablets)
Completed
- Norovirus Infection
- VXA-G1.1-NN
- +2 more
-
Cleveland, OhioRapid Medical Research
Apr 23, 2021
Poliomyelitis Trial in Wilrijk (Novel OPV2 candidate 1, Novel OPV2 candidate 2)
Completed
- Poliomyelitis
- Novel OPV2 candidate 1
- Novel OPV2 candidate 2
-
Wilrijk, Antwerp, Belgiumuniversity of Antwerp - centre for the evaluation of vaccination
Jan 14, 2021
Poliomyelitis Trial in Dhaka (SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A, SII Inactivated Salk Polio Vaccine
Recruiting
- Poliomyelitis
- SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A
- +3 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh
Dec 24, 2022
Diabetes, Type 1 Trial in Worldwide (Oral Insulin, Placebo)
Active, not recruiting
- Diabetes Mellitus, Type 1
- Oral Insulin
- Placebo
-
Leuven, Belgium
- +6 more
Apr 13, 2022
Vaccine Reaction Trial in Dhaka (Oral Polio Vaccine, Oral Cholera Vaccine)
Recruiting
- Vaccine Reaction
- Oral Polio Vaccine
- Oral Cholera Vaccine
-
Dhaka, BangladeshHazaribagh Field Clinic
Mar 30, 2022
Adverse Event Following Immunisation Trial (SABIN monovalent OPV2)
Completed
- Adverse Event Following Immunisation
- SABIN monovalent OPV2
- (no location specified)
Aug 1, 2020
Poliomyelitis Trial (Intradermal fractional dose inactivated polio vaccine (fIPV) in combination with recombinant double mutant
Recruiting
- Poliomyelitis
- Intradermal fractional dose inactivated polio vaccine (fIPV) in combination with recombinant double mutant heat labile toxin, LT(R192G/L211A), (dmLT)
- +2 more
-
Burlington, VermontUniversity of Vermont Vaccine Testing Center at the Larner Colle
Sep 2, 2022
Ebola Sudan Virus Disease Trial in Siaya, Kampala (cAD3-Sudan Ebolavirus Vaccine, Placebo)
Not yet recruiting
- Ebola Sudan Virus Disease
- cAD3-Sudan Ebolavirus Vaccine
- Placebo
-
Siaya, Kenya
- +1 more
Sep 7, 2023
Marburg Virus Disease Trial in Siaya, Kampala (cAd3-Marburg vaccine, Placebo)
Not yet recruiting
- Marburg Virus Disease
- cAd3-Marburg vaccine
- Placebo
-
Siaya, Kenya
- +1 more
Apr 17, 2023
Diphtheria Trial in Schoenau Am Koenigssee, Milano, Santiago de Compostela (DTPa-HBV-IPV/Hib, DTaP5-HBV-IPV-Hib, Pneumococcal
Completed
- Diphtheria
- DTPa-HBV-IPV/Hib
- +2 more
-
Rosenheim, Bayern, Germany
- +19 more
Jan 24, 2023
Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)
Not yet recruiting
- Influenza, Human
- FLU Q-PAN H5N8 Formulation 1
- +3 more
- (no location specified)
Jul 27, 2023
Shigella Trial in Baltimore (SF2a-TT15 Shigella Vaccine, Placebo, S. flexneri 2a strain 2457T Challenge Agent)
Recruiting
- Shigella
- SF2a-TT15 Shigella Vaccine
- +2 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
May 5, 2022
Poliomyelitis Trial in Kaifeng, Xuchang (Experimental vaccine, IPV control vaccine, single-person sIPV control vaccine)
Active, not recruiting
- Poliomyelitis
- Experimental vaccine
- +2 more
-
Kaifeng, Henan, China
- +1 more
May 24, 2022